Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach
Biotechnology and Applied Biochemistry · 2023
DOI: 10.1002/bab.2431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2023. Verfasst von Shahab Mahmoudvand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has shown rapid global spread and has resulted in a significant death toll worldwide. In this study, we aimed to design a multi‐epitope vaccine against SARS‐CoV‐2 based on structural proteins S, M, N, and E. We identified B‐ and T‐cell epitopes and then the antigenicity, toxicity, allergenicity, and similarity of predicted epitopes were analyzed. T‐cell epitopes were docked with corresponding HLA alleles. Consequently, the selected T‐ and B‐cell epitopes were included in the final construct. All selected epitopes were connected with different linkers and flagellin and pan‐HLA DR binding epitopes (PADRE) as an adjuvant were used in the vaccine construct. Furthermore, molecular docking was used to evaluate the complex between the final vaccine construct and two alleles, HLA‐A*02:01 and HLA‐DRB1*01:01. Finally, codons were optimized for in silico cloning into pET28a(+) vector using SnapGene. The final vaccine construct comprised 11 CTL, HTL, and B‐cell epitopes corresponding to 394 amino acid residues. In silico evaluation showed that the designed vaccine might potentially promote an immune response. Further in vivo preclinical and clinical testing is required to determine the safety and efficacy of the designed vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
- Department of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
ORCID-Profile: Shahab Mahmoudvand, Ruhollah Dorostkar
Zitieren
APA
Mahmoudvand, S., Esmaeili Gouvarchin Ghaleh, H., Jalilian, F. A., Farzanehpour, M., & Dorostkar, R. (2023). Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2431
Vancouver
Mahmoudvand S, Esmaeili Gouvarchin Ghaleh H, Jalilian FA, Farzanehpour M, Dorostkar R. Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach. Biotechnology and Applied Biochemistry. 2023. doi:10.1002/bab.2431
BibTeX
@article{Mahmoudvand2023,
author = {Mahmoudvand, Shahab and Esmaeili Gouvarchin Ghaleh, Hadi and Jalilian, Farid Azizi and Farzanehpour, Mahdieh and Dorostkar, Ruhollah},
title = {Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach},
journal = {Biotechnology and Applied Biochemistry},
year = {2023},
doi = {10.1002/bab.2431}
}
EUVIMED